{"id":4761,"date":"2026-10-15T03:13:54","date_gmt":"2026-10-15T03:13:54","guid":{"rendered":"https:\/\/nhdbio.com\/?p=4761"},"modified":"2026-10-15T03:13:54","modified_gmt":"2026-10-15T03:13:54","slug":"ss31-renal-ischemia-no-reflow-study","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/es\/ss31-renal-ischemia-no-reflow-study\/","title":{"rendered":"Vuelve el flujo de sangre, pero el tejido sigue sin ox\u00edgeno: un estudio renal de SS-31"},"content":{"rendered":"
\n

El flujo sangu\u00edneo regresa, pero el tejido a\u00fan carece de ox\u00edgeno: un estudio renal en SS-31<\/h2>\n

Reopening a large vessel does not guarantee that blood reaches every small vessel. A rat study linked SS-31, mitochondria and this \u201cno-reflow\u201d problem.<\/p>\n

\"El
Editorial illustration for explanation, not an experimental photograph.<\/figcaption><\/figure>\n

The main route can reopen while the smaller routes remain impaired<\/h3>\n

The kidney contains many small blood vessels. After the main blood supply returns, local tissue may still be poorly perfused because of cell injury, swelling and microcirculatory problems. This explains why restoring blood flow and restoring tissue function are different measurements. It is a conceptual explanation, not a diagnosis.<\/p>\n

How the 2014 paper approached the question<\/h3>\n

Researchers used a rat model with 45 minutes of renal ischemia, then examined mitochondrial, vascular and tissue changes during reperfusion and assessed SS-31 intervention. Follow-up extended to 4 weeks to examine capillary and arteriole loss, inflammation and fibrosis. The 45 minutes describe the model and 4 weeks describe observation. Neither sets a human use schedule.<\/p>\n

\"Rat
Teaching schematic. Numbers are hypothetical examples or explicitly identified study conditions described in the text.<\/figcaption><\/figure>\n

Why examine mitochondria and vessels together?<\/h3>\n

The study examined inner-membrane folds, or cristae, in endothelial and renal tubular epithelial mitochondria. The authors reported preservation of relevant structures with SS-31 and reductions in no-reflow and some later tissue injury. It suggests a research pathway: injury to cellular energy structures may affect microcirculatory recovery.<\/p>\n

Separate immediate and later endpoints<\/h3>\n

Structural and energy changes around reperfusion address the acute phase. Vessel density and fibrosis at 4 weeks address a later phase. Better later outcomes do not prove that each intervening step was separately established. Check the sample size, comparison groups and statistical method for each figure in the original paper.<\/p>\n

What this evidence supports<\/h3>\n

It supports further investigation of SS-31, mitochondria and microcirculation in this rat ischemia model. It is not human evidence for treating every kidney disease. Distinguish catalog research material from a specific formulation, and confirm structure, specifications and the information actually available. The illustrations explain the study; they are not experimental micrographs.<\/p>\n

Original sources and scope<\/h3>\n